Villa Sistemi boosts Del Global in Europe

Article

Officials at x-ray manufacturer Del Global Technologies believe the company has added an important European dimension to its Valhalla, NY-based business by increasing its ownership in Villa Sistemi Medicali, an Italian radiographic/fluoroscopic firm.In

Officials at x-ray manufacturer Del Global Technologies believe the company has added an important European dimension to its Valhalla, NY-based business by increasing its ownership in Villa Sistemi Medicali, an Italian radiographic/fluoroscopic firm.

In January, Del Global obtained a 19% stake in Villa along with the nonrevocable option to increase its share to 80%.

In April, Del Global decided to exercise its option.

Villa Sistemi has annual sales of $20 million. Its line of radiographic/fluoroscopic systems and a line of portable imaging systems with power ratings up to 30 kW complements Del Global’s existing line of products, said Leonard Trugman, Del Global’s president.

Getting into the European imaging market has been one of Del Global’s goals over the last five years, Trugman said. Before the Villa Sistemi acquisition, medical sales—systems and subsystems—accounted for 80% of Del Global’s total sales (SCAN 2/2/00). The acquisition drives that to 90%.

Prior to 1990, Del Global manufactured mostly defense electronics.

The company shifted toward medical imaging in the early 1990s, primarily by acquiring companies that specialized in niche technologies Del Global lacked (SCAN 2/2/00).

Del Global purchased x-ray and mammography firm DynaRad in 1992, and in 1996 bought Gendex Medical from Dentsply International. In 1998, Del Global acquired Acoma Medical Imaging for $1.4 million. That year, the company posted the strongest fourth-quarter and fiscal-year results in its history. Year-end sales for 1998 were $62.3 million (SCAN 11/11/98).

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Related Content
© 2025 MJH Life Sciences

All rights reserved.